DEBASISH TRIPATHY to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications DEBASISH TRIPATHY has written about Xenograft Model Antitumor Assays.
Connection Strength
0.047
-
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells. J Immunother Cancer. 2021 03; 9(3).
Score: 0.025
-
Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer. Mol Cancer Ther. 2019 02; 18(2):399-412.
Score: 0.022